Craniopharyngiomas are rare, partly cystic and calcified embryonic malformations of the
sellar/parasellar region with low histological grade (WHO Io). A bimodal age distribution has …

Craniopharyngiomas (CPs) are clinically aggressive tumors because of their invasive
behavior and recalcitrant tendency to recur after therapy. There are 2 types based on their …

Background Compared with photon therapy, proton therapy reduces exposure of normal
brain tissue in patients with craniopharyngioma, which might reduce cognitive deficits …

Introduction The transcranial approach (TCA) has historically been used to remove
craniopharyngiomas. Although the extended endoscopic endonasal approach (EEA) to …

Background Craniopharyngiomas show a high recurrence rate despite their pathologically
benign nature. Thus, we analyzed the clinical features to elucidate the prognostic factors for …

In recent years, the endoscopic endonasal approach (EEA) for craniopharyngiomas has
proven to be a safe option for extensive tumor resection, with minimal or no manipulation of …

Background Resective surgery remains the main treatment option for most patients with
craniopharyngiomas. Understanding of the microsurgical anatomy of the sella and …

Purpose This study uses a large-population national database to describe the presenting
clinical, sociodemographic, treatment, and clinical outcome differences between pediatric …

Purpose To report disease control and treatment-related side effects among adult patients
with craniopharyngioma treated with radiotherapy. Methods We performed a single …

Papillary craniopharyngioma (PCP) is a rare type of tumor, comprising∼ 20% of all
craniopharyngioma (CP) cases. It is now recognized as a separate pathological entity from …